baber/WOPTO huggingface dataset:
Patent DE-69306562-D1 (DE)
Inventor: LIGHTBODY DEREK CROSBY
IPC: F21V7/22
Filed: 1993-04-14
Granted: 1997-01-23
Abstract: PCT No. PCT/GB93/00781 Sec. 371 Date Oct. 14, 1994 Sec. 102(e) Date Oct. 14, 1994 PCT Filed Apr. 14, 1993 PCT Pub. No. WO93/21473 PCT Pub. Date Oct. 28, 1993.A light apparatus is provided for illuminating a subject with "soft light", i.e., diffused light that does not cast a defined shadow. The apparatus includes lamp holder (16), a lamp (14), a reflector (12) for reflecting light from the lamp towards the subject, a diffuser or a baffle (23) located in front of the lamp for preventing light from the lamp from passing directly onto the subject. The reflector has a reflecting surface at least 500 mm in diameter and composed of a plurality of convex light-reflecting elements less than 20 mm in diameter. The light reflecting elements (28) constitute at least 90% (by area) of the reflecting surface.
Patent DE-69315074-D1 (DE)
Inventor: SIBSON DAVID ROSS
IPC: C12Q1/6855
Filed: 1993-07-13
Granted: 1997-12-11
Abstract: PCT No. PCT/GB93/01452 Sec. 371 Date Jan. 13, 1995 Sec. 102(e) Date Jan. 13, 1995 PCT Filed Feb. 16, 1995 PCT Pub. No. WO94/01582 PCT Pub. Date Jan. 20, 1994A process for the categorization of nucleic acid sequences in which said sequences are linked to a population of adaptor molecules each exhibiting specificity for linking to a sequence including a predetermined nucleotide base, categorization of the resulting linked sequences being based upon selection for the base.
Patent DE-69315352-D1 (DE)
Inventor: BOYD JACK
IPC: C08L79/04
Filed: 1993-09-14
Granted: 1998-01-02
Abstract: Galvanic degradation under salt spray or salt water conditions in hybrid structures containing a corrosible metal and a conductive-fiber reinforced polymer matrix composite is reduced through the addition to the polymer matrix of the composite of an effective amount of an inorganic corrosion/degradation inhibitor.
Patent DE-69317898-D1 (DE)
Inventor: JOHANSSON ROLF
IPC: C07B57/00
Filed: 1993-11-05
Granted: 1998-05-14
Abstract: The invention relates to 3,3-diphenylpropylamines of formula (I), wherein R1 signifies hydrogen or methyl, R2 and R3 independently signify hydrogen, methyl, methoxy, hydroxy, carbamoyl, sulphamoyl or halogen, and X represents a tertiary amino group of formula (II), wherein R4 and R5 signify non-aromatic hydrocarbyl groups, which may be the same or different and which together contain at least three carbon atoms, and wherein R4 and R5 may form a ring together with the amine nitrogen, their salts with physiologically acceptable acids and, when the compounds can be in the form of optical isomers, the racemic mixture and the individual enantiomers. The invention also relates to methods for their preparation, pharmaceutical compositions containing the novel compounds, and the use of the compounds for preparing drugs
Patent DE-69317900-D1 (DE)
Inventor: THEUNISSEN JOSEPH
IPC: C11D3/39
Filed: 1993-11-19
Granted: 1998-05-14
Abstract: Method for the preparation of cristobalite, by treating sand having an overall iron and titanium content of less than 350 ppm and a titanium content of less than 200 ppm at elevated temperature in the presence of a catalyst and cristobalite obtainable by said method. Such cristobalite is used for the preparation of alkalimetal silicate, suitable for incorporation in detergent compositions comprising a bleach system based on active oxygen. The low metal content of the alkalimetal silicate used has a stabilising effect on the bleach system.
Patent DE-69321250-D1 (DE)
Inventor: HILLBURN RALPH
IPC: H01R9/05
Filed: 1993-10-21
Granted: 1998-10-29
Abstract: A shielded electric cable having a core including an insulated conductor. A first shielding member formed of an elongated ribbon of insulating material and a pair of elongated metal foil strips arranged in a parallel relationship with the ribbon and bonded to the opposite sides of the ribbon is applied longitudinally to the core and wrapped circumferentially therearound forming two concentric substantially closed shielded layers. A layer of plastic material, preferably foamed, surrounds the first shielding member and a second shielding member surrounds the plastic layer, the second shielding member being formed of non-braided metallic material. The layer of plastic material is bonded to the shielding members. The shielded electric cable is provided with an outer jacket of non-conducting material and having an appropriate O.D. for receiving a standard connector.
Patent DE-69322744-D1 (DE)
Inventor: BIANCHETTI GIULIA OTTAVIA
IPC: C11D1/825
Filed: 1993-07-12
Granted: 1999-02-04
Abstract: Stable aqueous emulsions are disclosed which comprise hydrophobic and hydrophilic nonionic surfactants and a ethylenediamine-N,N'-disuccinic acid. Ethylenediamine-N,N'-disuccinic acid builds viscosity in said emulsions.
Patent DE-69328953-D1 (DE)
Inventor: HASEGAWA KOJI
IPC: A01N43/16
Filed: 1993-03-12
Granted: 2000-08-10
Abstract: A compound represented by the formula (I) <CHEM> wherein R<1>, R<2>, R<3>, R<4>, and R<5> each independently represents hydrogen, acetyl or benzyl, R<6> represents hydrogen, hydroxyl, acetoxy, or benzyloxy, R<7> represents hydrogen, or R<6> and R<7> together represent a direct bond, and R<8> represents carboxyl, methoxycarbonyl, hydroxymethyl, or acetoxymethyl; or a salt thereof. The compound is useful for plant culture, growth inhibition of moyashi roots, and growth promotion of moyashi hypocotyls.
Patent DE-69330962-D1 (DE)
Inventor: PETERSSON JAN
IPC: A61M15/00
Filed: 1993-11-23
Granted: 2001-11-22
Abstract: PCT No. PCT/SE93/01007 Sec. 371 Date May 23, 1995 Sec. 102(e) Date May 23, 1995 PCT Filed Nov. 23, 1993 PCT Pub. No. WO94/12230 PCT Pub. Date Jun. 9, 1994A multiple dose inhaler for the inhalation of a dry powder medicament is provided. The inhaler includes (a) a housing defining an inlet, an outlet spaced from the inlet, and an airflow path from the inlet to the outlet; (b) an elongate carrier disposed within the housing, a first portion of which carries discrete doses of the medicament, the doses being spaced from one another at predetermined substantially equidistant intervals along the length of the elongate carrier; (c) a dispensing wheel upon which the first portion of the carrier is wound; (d) a take-up wheel constructed to incrementally receive the elongate carrier from the dispensing wheel as it is unwound therefrom during use; (e) an advancement mechanism constructed to incrementally advance the elongate carrier within the housing from the dispensing wheel to the take-up wheel when the inhaler is actuated for use; (f) a brake constructed to releasably resist further advancement of the elongate carrier by the advancement mechanism after the elongate carrier has advanced an incremental distance substantially equal to the predetermined distance between the discrete doses; and (g) a trigger constructed to engage and release the brake, allowing further advancement of the elongate carrier.
Patent DE-69333649-D1 (DE)
Inventor: KIEVTS TIM
IPC: C12Q1/6865
Filed: 1993-08-20
Granted: 2004-11-11
Abstract: The present invention relates to an improved method for the amplification of nucleic acid. The invention is characterized in that ribonucleotides are introduced during amplification that weaken normal basepairing. Preferably the ribonucleotides are inosine-triphosphate nucleotides which partly substitute guanine-triphosphate nucleotides normally present in the amplification reaction mixture. The incorporation of nucleotides, during amplification, that weaken normal base pairing prevents the formation of secondary structures in the amplificate. The efficiency of the amplification is thereby increased. The introduction, during amplification, of nucleotides that weaken normal base pairing also results in an improved sensitivity during detection of the amplified nucleic acid, when the detection method comprises the hybridization of the amplified nucleic acid to a complementary sequence.
Patent DE-69412274-D1 (DE)
Inventor: BOER CORNELIS
IPC: H04L12/56
Filed: 1994-09-06
Granted: 1998-09-10
Abstract: PCT No. PCT/EP94/02951 Sec. 371 Date Mar. 6, 1996 Sec. 102(e) Date Mar. 6, 1996 PCT Filed Sep. 6, 1994 PCT Pub. No. WO95/07586 PCT Pub. Date Mar. 16, 1995Determining, in a transport network, a link between a source and a destination. The network is partitioned into subnetworks between which sublinks are determined. Each subnetwork has access points which indicate the transport capacity of the subnetwork between the access points. The sublinks, in each case, extend from a first access point to a second access point. In a network having a distributed control, the sublinks are determined successively between the link already determined and a remaining subnetwork. In this arrangement, the remaining subnetwork, in each case, includes an access point already associated with the destination and does not include an access point already associated with the link. Preferably, the access points, in each case, indicate the available capacity of a subnetwork.
Patent DE-69412338-D1 (DE)
Inventor: CALCATERRA ENRICO
IPC: B09B1/00
Filed: 1994-05-02
Granted: 1998-09-17
Abstract: The process includes: preparing the untreated waste (1) into bales (3); a waste stabilization treatment that uses the combination of microbiological aerobic and/or anaerobic processes and natural and/or artificial drying, preparing stacks with appropriately arranged bales; covering the bales with materials (13) that are suitable to prevent the penetration of water or other liquids into the bales; placing the bales in a dumping site (15). <IMAGE>
Patent DE-69426517-D1 (DE)
Inventor: ZARDI UMBERTO
IPC: C07C29/152
Filed: 1994-10-12
Granted: 2001-02-08
Abstract: In a method of modernizing a heterogeneous exothermic synthesis reactor (1) of the type comprising an external shell (2), in which at least one catalytic bed (15, 16, 17) is supported, the catalytic bed (15, 16, 17) is connected to an external boiler (21), for generating high pressure steam, by means of a reacted gas outlet nozzle (4) and a conduit (29) extending in said nozzle (4) thereby forming an annular airspace (30). Advantageously, the airspace (30) defines an outlet flowpath of the gases cooled in the boiler (21) which avoids overheating of the nozzle (4). <IMAGE>
Patent DE-69431747-D1 (DE)
Inventor: CHIESI PAOLO
IPC: A61K47/48
Filed: 1994-01-26
Granted: 2003-01-02
Abstract: PCT No. PCT/EP94/00205 Sec. 371 Date Nov. 15, 1995 Sec. 102(e) Date Nov. 15, 1995 PCT Filed Jan. 26, 1994 PCT Pub. No. WO94/16733 PCT Pub. Date Aug. 4, 1994A multicomponent inclusion complex of a basic drug, an acid and a cyclodextrin has enhanced water-solubility.
Patent DE-69434826-D1 (DE)
Inventor: HAMALAINEN JARI
IPC: H04W72/04
Filed: 1994-09-05
Granted: 2006-09-28
Abstract: A communications system comprises a mobile communication means and a fixed communication means. The mobile communication means is configured to store a parameter of the fixed communication means for setting up a virtual data communication channel with it. The fixed communication means is configured to store a parameter of the mobile communication means for setting up a virtual data communication channel with it. At least one of said mobile communication means and said fixed communication means is configured to expedite establishment of a real data communication channel through application of a previously stored parameter of the other communication means.
Patent DE-69435212-D1 (DE)
Inventor: NARDI RONALD V
IPC: A61P5/48
Filed: 1994-01-24
Granted: 2009-07-16
Abstract: A composition comprising (i) a prepograstrin peptide precursor gene and (ii) an EGF receptor ligand gene capable of being stably introduced into pancreatic cells such that their expression can stimulate pancreatic islet precursor cells for use in a method of treatment of diabetes mellitus.
Patent DE-69435268-D1 (DE)
Inventor: DAGGETT LORRIE
IPC: G01N33/15
Filed: 1994-06-03
Granted: 2010-04-01
Abstract: In accordance with the present invention, there are provided nucleic acids encoding human metabotropic glutamate receptor subtypes and the proteins encoded thereby. In a particular embodiment, the invention nucleic acids encode mGluR1, mGluR2, mGluR3 and mGluR5 subtypes of human metabotropic glutamate receptors. In addition to being useful for the production of metabotropic glutamate receptor subtypes, these nucleic acids are also useful as probes, thus enabling those skilled in the art, without undue experimentation, to identify and isolate related human receptor subunits. In addition to disclosing novel metabotropic glutamate receptor subtypes, the present invention also comprises methods for using such receptor subtypes to identify and characterize compounds which affect the function of such receptors, e.g., agonists, antagonists, and modulators of glutamate receptor function.
Patent DE-69514424-D1 (DE)
Inventor: VAN WEZEL MICHEL MARTINUS WILL
IPC: F24H1/40
Filed: 1995-06-15
Granted: 2000-02-17
Abstract: A heat exchanger comprises: a plurality of substantially mutually parallel metal pipes (3) through which liquid can flow; a space at least partially bounded by these pipes (3) in which a burner can be accommodated such that the heat coming from the burner can heat via the walls of the pipes the liquid flowing therethrough; which pipes are fixed with their ends in stainless steel end plates (1,2) which are provided with holes into which the pipes fit, which holes are ordered in a predetermined pattern; which end plates (1,2) co-act sealingly with respective end walls (10,11) which together with these end plates (1,2) form compartments through which the liquid flowing through the pipes can flow; between which end plates (1,2) at least one closed side wall (12,13) extends which forms a side boundary of the space in which the pipes are situated while leaving free the said space for the burner and an outlet space situated on the other side of the pipes which connects to an outlet for flue gases; which pipes are of stainless steel with a wall thickness of (0.5 +/- 0.2) mm and are ordered in a pattern such that in a region through which the flue gases flow they have mutual distances of (1.0 +/- 0.5) mm. <IMAGE>
Patent DE-69514808-D1 (DE)
Inventor: LEE HEUNG-SIK
IPC: H01R12/55
Filed: 1995-07-31
Granted: 2000-03-02
Abstract: PCT No. PCT/IB95/00678 Sec. 371 Date Jan. 21, 1997 Sec. 102(e) Date Jan. 21, 1997 PCT Filed Jul. 31, 1995 PCT Pub. No. WO96/04695 PCT Pub. Date Feb. 15, 1996The present invention relates, in general, to an improvement of a hybrid connector, and a right angle female member and male members therefor. A male member (11) comprises a projection pin (11a) formed to at one end and having a driver slot formed therein, and a flange (11b) and a screw hole (11c) formed at the other end, the flange having teeth It formed thereon. Also, the other male member (12) comprises a screw portion (12a) provided at one end lie and threadedly engaged with a screw hole (11c) of the male member (11), a projection pin (12b) provided at the other end and having a driver slot formed therein, and a flange (12c) provided between the screw portion (12a) and the projection pin (12b). A right angle female member (13) comprises a body portion, (13a) having six legs (13a1), a rectangular rod shaped body (13a2), and a plug portion receiving hole (13a3) formed through the body portion, and a cylindrical hollow plug portion (13b) having a first end (13b1) for fitting into the plug portion receving hole (13a3), a second end (13b2) in which a projection pin of a male member for a hybrid connector is fitted, and a flange portion (13b3) formed between the first and second ends. A hybrid connector is constituted by a suitable combination of the first and second male members (11 and 12) and the right angle female member (13) and provides for improved electrical passages which will enable large quantities of current to flow through them.
Patent DE-69521500-D1 (DE)
Inventor: KUROKI YASUHISA
IPC: C07F9/6512
Filed: 1995-02-27
Granted: 2001-08-02
Abstract: The invention provides a phosphonic diester derivative of the formula: <CHEM> wherein R<1>, R<2>, R<3> and R<6> are the same or different and each represents a hydrogen atom, a lower alkyl group, a halogen atom, a nitro group, a lower alkoxy group, a cyano group, a phenylsulfonylamino group, a benzoylamino group, an amino group or a halogen-substituted lower alkyl group, R<4> represents a phenyl group, a lower alkyl group, a phenyl(lower)alkyl group optionally substituted by halogen on the phenyl ring, a lower alkenyl group, a carboxy(lower)alkyl group, a (lower)alkoxy-carbonyl(lower)alkyl group, a (lower)alkoxy(lower)alkyl group, a lower alkynyl group, a benzoyl(lower)alkyl group, an amino group, a di(lower)alkanoylamino group, a benzylideneamino group optionally having lower alkoxy on the phenyl ring or a pyridylmethylideneamino group, R<5> represents a lower alkyl group, R<7> represents a lower alkoxy group, a hydroxyl group, a phenyl group, a phenyl(lower)alkoxy group optionally having halogen on the phenyl ring or a phenyl(lower)alkylamino group, X<1> and X<2> independently represent an oxygen atom or a sulfur atom, A represents an oxygen atom or a single bond, and Z represents a lower alkylene group. The derivatives according to the invention are useful as therapeutic or preventive compositions for hyperlipidemia, hypertension, and diabetes.
Patent DE-69530310-D1 (DE)
Inventor: SEARE WILLIAM J JR
IPC: A61F2/82
Filed: 1995-10-17
Granted: 2003-05-15
Abstract: The methods and apparatus of the present invention permit stable transcutaneous access. Some preferred embodiments of the invention provide body pocket access channels that provide stable means for communicating between the exterior of the body and a natural or created internal body pocket. Other embodiments involve the inclusion of an attachment element surrounding a device sought to be passed from a location external of a patient's body to a location within the body at the exit site, but which are attached to the device at a location within the body rather than at the exact location where the device passes through a patient's skin, thereby forming a body pocket that will reduce stress or strain at the exit site. Several alternative embodiments for effecting body pockets through use of attachment elements are disclosed.
Patent DE-69531388-D1 (DE)
Inventor: BASCOULERGUE GERARD
IPC: A61B17/14
Filed: 1995-10-27
Granted: 2003-09-04
Abstract: The guide consists of an adjustable and telescopic extra-medullary sighting rod (6), a cutter guide (54) and a feeler (64). It also has a tibial plate marker bar (9), an ankle alignment stirrup (20) with a slider (27) and regulating nut (30), an adjustable head support (40) and a working head (48) which receives the feeler and cutter guide. The ankle alignment stirrup has two opposite points defining an ankle alignment axis on two branches connected to the slider (27). The points are equipped with bone penetration screws and locking members. The head support (40) has a tube (41) at the proximal end of the sighting rod, a regulator, and a ring (44) on the end of the tube to receive a graduated pillar (50) on the working head.
Patent DE-69612317-D1 (DE)
Inventor: CASAGRANDE SERGIO
IPC: E21B3/025
Filed: 1996-01-30
Granted: 2001-05-10
Abstract: Casing rotating device (10) for drilling machines, the device being associated and coaxial with a device (13) for the rotation of a drilling tool for the obtaining of foundation piles, the drilling tool rotation device (13) having its own motor, the rotary casing-oscillator device (10) being located in a position below the drilling tool rotation device (13) and being associated with a reduction-gear and torque-multiplier transmission assembly (15,115).
Patent DE-69614110-D1 (DE)
Inventor: TREBOSC MARIE-THERESE
IPC: A61K8/41
Filed: 1996-05-21
Granted: 2001-08-30
Abstract: PCT No. PCT/FR96/00756 Sec. 371 Date Nov. 21, 1997 Sec. 102(e) Date Nov. 21, 1997 PCT Filed May 21, 1996 PCT Pub. No. WO96/37180 PCT Pub. Date Nov. 28, 1996The present invention relates to a pharmaceutical and/or cosmetic composition in the form of a stabilized pseudoemulsion, characterized in that it is essentially comprised of (1) at least one aqueous phase containing a single gelifying agent selected from the group comprising polyoses, such as gelose, the xanthane gums, cellulose, alginates, semisynthetic derivatives of cellulose, and acrylic polymers such as Synthalen TM ; (2) at least one lipidic phase containing at least one consistency factor, with a ratio consistency factor/total lipidic phase between about 0.06 and 0.18, and in that said composition is free of surfactants. It also relates to a process for preparing such composition.
Patent DE-69623028-D1 (DE)
Inventor: DUBIEF CLAUDE
IPC: C08L83/10
Filed: 1996-10-08
Granted: 2002-09-19
Abstract: The present invention relates to a cosmetic or dermatological for the treatment of keratinous materials, particularly hair, comprising in a cosmetically or dermatologically acceptable medium at least a grafted silicone polymer with a polysiloxane skeleton grafted by organic non-silicone monomers and at least an aqueous dispersion of insoluble particles of nonionic or cationic polymer. The composition is particularly useful for rinsed products or as non rinsed products for washing hair, hair care, hair conditioning, hair dressing or hair setting.
Patent DE-69637932-D1 (DE)
Inventor: TOMPKIN WAYNE ROBERT
IPC: G06K19/06
Filed: 1996-11-14
Granted: 2009-06-25
Abstract: An optical information carrier is in the form of a composite laminate having diffractive first relief structures (10) embossed into the underside (4) of the carrier foil (3) to produce visual optical-diffractive effects and optionally diffractive second relief structures (10) embossed into the top side (5) of the carrier foil (3). The top side (5) are provided with an optically effective relief structure (7) formed by layers of a dielectric (9) which form a machine readable information by covering or exposing the relief structure (15) of the underside (4) along a data track. A lacquer layer (29) covers the dielectric layers (9) and the neighbouring parts of the top side (5). The dielectric layers (9) differ in refractive index from the refractive indices of the adjoining materials of the carrier foil (3) and the lacquer layer (29). The materials of the carrier foil (3) and the lacquer layer (29) may have the same refractive index and allow light impinging on the top side (5) to penetrate at least partially into the composite laminate. <IMAGE>
Patent DE-69702527-D1 (DE)
Inventor: BAGSHAWE DAWSON
IPC: A61K47/48
Filed: 1997-11-28
Granted: 2000-08-17
Abstract: A three component therapeutic system comprising (i) a first compound, (ii) a catalytic macromolecule which does not specifically bind to a tumour antigen but which is capable, following administration to the vascular compartment of a mammal, of being taken up by a tumour in the mammal and is capable of converting the first compound into a second compound, and (iii) an inhibitor which, following administration to the said vascular compartment, reduces the level of the said catalytic conversion activity in the vascular compartment.
Patent DE-69709640-D1 (DE)
Inventor: BASTIAANSEN WILHELMUS
IPC: D01F6/46
Filed: 1997-05-29
Granted: 2002-02-21
Abstract: An elastic fiber of a mixture containing a copolyether ester or a copolyester ester and a chemically crosslinked rubber, which fiber has a permanent elongation after 100% stretching of at most 9% and an elongation at break of at least 450% and a process for producing an elastic fiber comprising the melt spinning of a mixture of a copolyether ester or a copolyester ester and a rubber to form a fiber, in which the rubber is completely or almost completely crosslinked at the moment the fiber is formed, and are disclosed.